急什么？优化非ST段抬高急性冠状动脉综合征的 P2Y12 抑制时机

IF 21.7 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of the American College of Cardiology Pub Date : 2024-11-15 DOI:10.1016/j.jacc.2024.10.099

Joseph M. Kim, Robert W. Yeh, Eric A. Secemsky

{"title":"急什么？优化非ST段抬高急性冠状动脉综合征的 P2Y12 抑制时机","authors":"Joseph M. Kim, Robert W. Yeh, Eric A. Secemsky","doi":"10.1016/j.jacc.2024.10.099","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Funding Support and Author Disclosures</h2>Dr Kim has received research funding from the National Institutes of Health (T32HL160522). Dr Yeh has received research funding from Boston Scientific, Abbott, and Medtronic; and has served as a consultant for Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, CathWorks, and Shockwave. Dr Secemsky has received research funding from the National Institutes of Health National Heart, Lung, and Blood Institute (K23HL150290), the U.S. Food and Drug Administration, SCAI, Abbott/CSI, Becton</section></section>","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"35 1","pages":""},"PeriodicalIF":21.7000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What Is the Rush?: Optimizing the Timing of P2Y12 Inhibition in Non–ST-Segment Elevation Acute Coronary Syndromes\",\"authors\":\"Joseph M. Kim, Robert W. Yeh, Eric A. Secemsky\",\"doi\":\"10.1016/j.jacc.2024.10.099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Funding Support and Author Disclosures</h2>Dr Kim has received research funding from the National Institutes of Health (T32HL160522). Dr Yeh has received research funding from Boston Scientific, Abbott, and Medtronic; and has served as a consultant for Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, CathWorks, and Shockwave. Dr Secemsky has received research funding from the National Institutes of Health National Heart, Lung, and Blood Institute (K23HL150290), the U.S. Food and Drug Administration, SCAI, Abbott/CSI, Becton</section></section>\",\"PeriodicalId\":17187,\"journal\":{\"name\":\"Journal of the American College of Cardiology\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":21.7000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jacc.2024.10.099\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacc.2024.10.099","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

章节片段资金支持和作者披露 Kim 博士曾接受美国国立卫生研究院 (T32HL160522) 的研究资助。Yeh 博士曾获得波士顿科学公司、雅培公司和美敦力公司的研究资助；并曾担任波士顿科学公司、雅培公司、美敦力公司、Edwards Lifesciences、CathWorks 和 Shockwave 的顾问。Secemsky 博士曾获得美国国立卫生研究院国家心肺血液研究所 (K23HL150290)、美国食品和药物管理局、SCAI、雅培/CSI、Becton、Medtron、Boston Scientific、Medtron、Edwards Lifesciences、CathWorks 和 Shockwave 的研究资助。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

What Is the Rush?: Optimizing the Timing of P2Y12 Inhibition in Non–ST-Segment Elevation Acute Coronary Syndromes

Section snippets

Funding Support and Author Disclosures

Dr Kim has received research funding from the National Institutes of Health (T32HL160522). Dr Yeh has received research funding from Boston Scientific, Abbott, and Medtronic; and has served as a consultant for Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, CathWorks, and Shockwave. Dr Secemsky has received research funding from the National Institutes of Health National Heart, Lung, and Blood Institute (K23HL150290), the U.S. Food and Drug Administration, SCAI, Abbott/CSI, Becton

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of the American College of Cardiology 医学-心血管系统

CiteScore

42.70

自引率

3.30%

发文量

5097

审稿时长

2-4 weeks

期刊介绍： The Journal of the American College of Cardiology (JACC) publishes peer-reviewed articles highlighting all aspects of cardiovascular disease, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers and viewpoints. Content Profile: -Original Investigations -JACC State-of-the-Art Reviews -JACC Review Topics of the Week -Guidelines & Clinical Documents -JACC Guideline Comparisons -JACC Scientific Expert Panels -Cardiovascular Medicine & Society -Editorial Comments (accompanying every Original Investigation) -Research Letters -Fellows-in-Training/Early Career Professional Pages -Editor’s Pages from the Editor-in-Chief or other invited thought leaders